8-K: Current report
3: Initial statement of beneficial ownership of securities-Director Kim Sang Hyun
S-4: Registration of securities issued in business combination transactions
8-K: Current report
8-K: Current report
3: Initial statement of beneficial ownership of securities-Director Lee Phil Geon
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
10-Q: Quarterly report
8-K: Current report
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
DEF 14A: Definitive information statements
8-K: Current report
10-K: Annual report
PRE 14A: Preliminary proxy statements relating to merger or acquisition
Bellevue Life Sciences Acquisition Corp. | 8-K: Current report
Bellevue Life Sciences Acquisition Corp. | NT 10-K: Others
No Data